Expand PRTA Menu
PRTA MENU

PRTA Stock Summary and Trading Ideas (Prothena PLC - | NASDAQ:PRTA)

Charts for Today's Stock Price and Implied Volatility in Prothena PLC -

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for PRTA by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Prothena PLC - (PRTA) Frequently Asked Questions

What does Prothena PLC - do?

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

What symbol and exchange does Prothena PLC - stock trade?

Prothena PLC - trades on the NASDAQ stock market under the symbol PRTA.

What is Prothena PLC - stock price doing today?

As of May 9, 2024, PRTA stock price declined to $22.24 with 82,883 million shares trading.

What is Prothena PLC -'s Beta?

PRTA has a beta of 0.80, meaning it tends to be less sensitive to market movements. PRTA has a correlation of 0.02 to the broad based SPY ETF.

How much is Prothena PLC - worth?

PRTA has a market cap of $1.19 billion. This is considered a Small Cap stock.

How much money does Prothena PLC - make?

Last quarter Prothena PLC - reported $50,000 in Revenue and -$1.34 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.14.

What is the highest and lowest price Prothena PLC - traded in the last 3 year period?

In the last 3 years, PRTA stock traded as high as $79.75 and as low as $19.65.

What are the top ETFs holding Prothena PLC -?

The top ETF exchange traded funds that PRTA belongs to (by Net Assets): XBI, IWM, VXF, IWO, IBB.

Is Prothena PLC - (PRTA) a good investment?

PRTA has underperformed the market in the last year with a return of -71.1%, while the SPY ETF gained +27.3%. In the last 3 month period, PRTA fell short of the market, returning -18.9%, while SPY returned +4.4%. However, in the most recent 2 weeks PRTA has outperformed the stock market by returning +8.2%, while SPY returned +2.6%.

What is the support and resistance for Prothena PLC - (PRTA) stock price?

PRTA support price is $22.27 and resistance is $23.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRTA stock will trade within this expected range on the day.